Company

Ohara Pharmaceutical Co.,Ltd.

Ohara Pharmaceutical Co., Ltd. develops and sells drugs for chronic myeloid leukemia and pediatric cancers from Shiga, Japan.

About

Founded in 1964 in Shiga, Japan, Ohara Pharmaceutical Co., Ltd. develops and commercializes pharmaceuticals focused on hematology and oncology, including therapies for chronic myeloid leukemia and pediatric cancers. Its products include generic formulations and its flagship Macrogolase® for injection, sold mainly in Japan and parts of Asia and Europe, and it reported revenue of USD 157.11 mn in 2023. JIC Venture Growth Investments invested on June 30, 2025, with terms undisclosed, and the company is at the Seed stage.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in